Daily Anesthesiology Research Analysis
Analyzed 24 papers and selected 3 impactful papers.
Summary
Comparative perioperative research highlights show practical gains in anesthetic strategy and analgesia. A target trial emulation across thrombectomy trials suggests non-general anesthesia improves 90-day functional independence in young adults, while a randomized trial in mastectomy supports PECS or paravertebral blocks over erector spinae plane blocks for better recovery metrics. A prospective cohort indicates perioperative plasma exosomal microRNAs may enable earlier detection of acute kidney injury in septic surgical patients.
Research Themes
- Neurointerventional anesthesia strategy and outcomes
- Optimization of regional anesthesia for breast surgery
- Perioperative biomarkers for early kidney injury detection
Selected Articles
1. General Anesthesia Versus Non-General Anesthesia in Young Adults Undergoing Thrombectomy.
In a pooled target trial emulation of 284 young adults undergoing EVT, non-general anesthesia was associated with a 12% absolute increase in 90-day functional independence compared with general anesthesia and lower pneumonia risk. Reperfusion success, mortality, and symptomatic intracranial hemorrhage were similar, supporting non-GA selection pending a definitive randomized trial.
Impact: Addresses a persistent controversy in neurointerventional anesthesia using modern causal inference on individual patient data, with clinically meaningful outcome differences.
Clinical Implications: For eligible young adults undergoing EVT, prioritize non-general anesthesia when feasible to maximize functional recovery and minimize pneumonia, while maintaining team readiness to convert if needed.
Key Findings
- Non-GA increased 90-day functional independence versus GA (risk difference 0.12; 95% CI 0.02–0.25).
- GA was associated with higher pneumonia incidence (risk difference -0.21; 95% CI -0.35 to -0.11).
- Reperfusion success (eTICI ≥2b), mortality, and sICH did not significantly differ between groups.
Methodological Strengths
- Target trial emulation with individual patient data pooled from three trials
- Robust causal inference using IPTW and G-computation with multiple outcomes
Limitations
- Anesthetic modality not randomized; potential residual confounding remains
- Focus on young adults limits generalizability to older populations
Future Directions: Conduct a dedicated randomized trial comparing GA versus non-GA in EVT with standardized anesthetic protocols and patient-centered outcomes.
BACKGROUND: Endovascular thrombectomy (EVT) is the standard of care for eligible patients with anterior circulation large vessel occlusion (LVO). The optimal anesthetic strategy during EVT for young adults with LVO remains unclear. METHODS: Using target trial emulation, we performed a pooled analysis of individual patient data from the DEVT, RESCUE BT, and MARVEL trials. We compared anesthetic strategies (general anesthesia [GA] vs. non-GA [conscious sedation/local anesthesia]) during EVT in patients aged 18-50 years. The primary outcome was 90-day functional independence (modified Rankin Scale [mRS] 0-2). Secondary outcomes included ordinal mRS shift, excellent outcome (mRS 0-1), favorable outcome (mRS 0-3), successful reperfusion (expanded Thrombolysis in Cerebral Infarction [eTICI] grade ≥2b), early neurological improvement (ENI), pneumonia, mortality, and symptomatic intracranial hemorrhage (sICH). Average treatment effects were estimated via inverse probability of treatment weighting (IPTW) and G-computation, with risk differences (RDs) and (common) odds ratios (ORs) reported. RESULTS: Among 284 included patients in the target trial, 94 received GA and 190 received non-GA. Non-GA was associated with higher rates of 90-day functional independence (mRS 0-2) compared to GA (RD 0.12, 95%CI: 0.02 to 0.25). GA was associated with increased pneumonia incidence (RD -0.21, 95%CI: -0.35 to -0.11). Additionally, reperfusion success, mortality, and sICH rates did not differ significantly between groups. CONCLUSION: In this emulated trial involving young stroke patients undergoing EVT, non-GA was associated with a higher likelihood of functional independence compared to GA with similar reperfusion success and sICH. These findings may inform anesthetic selection for young adults with anterior circulation LVO pending a dedicated randomized trial. TRIAL REGISTRATION: ChiCTR.org.cn Identifier: ChiCTR-IOR-17013568; ChiCTR-IOR-17014167; ChiCTR2100051729.
2. Comparison of erector spinae plane, paravertebral, and pectoral nerve blocks on postoperative analgesia and Quality of Recovery-15 in patients undergoing mastectomy: a prospective randomized trial.
In 90 women undergoing mastectomy, TPVB and PECS blocks reduced 24-hour morphine consumption and improved QoR-15 compared with ESPB, with TPVB offering the longest time to first opioid request. Pain scores and PONV were similar across groups, supporting PECS or TPVB as preferred components of multimodal analgesia.
Impact: Direct, randomized comparison of three widely adopted regional techniques provides actionable guidance for breast surgery analgesia and recovery optimization.
Clinical Implications: Favor TPVB or PECS over ESPB for mastectomy when feasible to reduce opioid needs and enhance recovery quality, while standardizing protocols and monitoring for block-specific risks.
Key Findings
- 24-hour morphine consumption was higher with ESPB (median 10 mg) than TPVB (9 mg; p=0.009) and PECS (9 mg; p=0.018).
- Time to first morphine request was shortest in ESPB; TPVB provided the longest analgesic duration (p<0.001).
- QoR-15 scores were significantly lower in ESPB compared with TPVB and PECS (p<0.001), while VAS pain and PONV did not differ.
Methodological Strengths
- Prospective three-arm randomized design with standardized general anesthesia
- Pre-registered trial with clearly defined primary and secondary outcomes
Limitations
- Single-center and moderate sample size may limit generalizability
- Primary follow-up limited to 24 hours; longer-term pain and chronic pain outcomes not assessed
Future Directions: Evaluate longer-term pain, chronic pain development, and cost-effectiveness of TPVB vs PECS across diverse patient populations and surgical extents.
BACKGROUND: Modified radical mastectomy (MRM) is frequently associated with moderate to severe postoperative pain, which may negatively affect recovery and quality of life. Regional anesthesia techniques such as the erector spinae plane block (ESPB), thoracic paravertebral block (TPVB), and pectoral nerve block (PECS) have been increasingly used as part of multimodal analgesia strategies for breast surgery. However, their comparative effects on analgesic efficacy and quality of recovery remain unclear. METHODS: The study included 90 female patients undergoing unilateral elective MRM. Patients were randomly allocated into three groups (n = 30 each) to receive ESPB, TPVB, or PECS block preoperatively with 0.25% bupivacaine. All patients subsequently underwent standardized general anesthesia. Postoperative pain was assessed using the Visual Analog Scale (VAS) at 0, 1, 3, 6, 12, and 24 h. The primary outcome was total morphine consumption at 24 h. Secondary outcomes included time to first morphine request, incidence of rescue fentanyl use, postoperative nausea and vomiting, patient satisfaction, and scores. RESULTS: Demographic characteristics and operative durations were comparable among the groups (p > 0.05). Total 24-hour morphine consumption was significantly higher in the ESPB group (median 10 mg) compared with TPVB (9 mg, p = 0.009) and PECS (9 mg, p = 0.018) groups. Kaplan-Meier analysis revealed that the time to first morphine request was significantly shorter in the ESPB group (p < 0.001), while TPVB provided the longest analgesic duration. No significant differences were found in postoperative pain scores, rescue opioid requirements, or nausea-vomiting incidence (p > 0.05). QoR-15 scores were significantly lower in the ESPB group compared with TPVB and PECS groups (p < 0.001). CONCLUSION: Both PECS and TPVB provided superior postoperative analgesia and better quality of recovery scores compared to ESPB in patients undergoing modified radical mastectomy. These findings support the use of PECS or TPVB as effective components of multimodal analgesia strategies for breast cancer surgery. TRIAL REGISTRATION: ISRCTN Registry, ISRCTN17247698.
3. Plasma exosomal microRNAs as early predictors of subclinical acute kidney injury in septic patients undergoing major non-cardiac surgery: a prospective observational cohort study.
In 120 septic adults undergoing major surgery with serial perioperative sampling, specific plasma exosomal miRNAs differed in patients who developed AKI and demonstrated clinically relevant ROC performance across time points. Findings support exosomal miRNAs as promising early biomarkers for clinical and subclinical AKI, warranting validation.
Impact: Introduces a perioperative liquid biopsy approach using exosomal miRNAs to detect renal injury before creatinine changes, addressing a high-morbidity outcome in anesthesiology and critical care.
Clinical Implications: If validated, perioperative exosomal miRNA panels could enable earlier AKI risk stratification and renoprotective interventions in septic surgical patients, including for subclinical injury.
Key Findings
- Serial perioperative plasma exosomal miRNAs showed distinct alterations in patients who developed AKI versus those who did not.
- Candidate miRNAs achieved clinically relevant AUCs for early AKI detection across pre-, intra-, and 24-hour postoperative time points.
- Subclinical AKI was defined by urinary TIMP-2×IGFBP7 > 0.3 without creatinine rise, and miRNA changes were observed in this context.
Methodological Strengths
- Prospective cohort with predefined KDIGO and subclinical AKI definitions and serial perioperative sampling
- Diagnostic performance assessed via ROC analyses across multiple time points
Limitations
- Single-center study with limited follow-up to 24 hours; external validation needed
- Abstract does not report exact AUC values or event counts, limiting effect size interpretation without full text
Future Directions: Perform multicenter validation with standardized miRNA platforms, report calibration/decision-curve analyses, and test biomarker-guided renoprotective strategies.
Early identification of acute kidney injury (AKI), including subclinical AKI, remains a critical challenge in septic patients undergoing major non-cardiac surgery. Exosomal microRNAs (miRNAs) represent emerging biomarkers capable of reflecting early renal cellular stress before detectable changes in serum creatinine occur. This prospective observational cohort study enrolled 120 adult septic patients undergoing major non-cardiac surgery (> 2 h) at Imam Sajjad Hospital, Tabriz, between early 2025 and August 2025 (Ethics Approval ID: IR.IAU.TABRIZ.REC.1404.179). Peripheral blood was obtained at three perioperative time points (preoperative, intraoperative, and 24 h postoperative) for exosome isolation and miRNA quantification. Clinical AKI was defined according to KDIGO criteria. Subclinical AKI was defined as urinary TIMP-2 × IGFBP7 > 0.3 in the absence of any rise in serum creatinine. Diagnostic performance of candidate miRNAs was assessed using receiver operating characteristic (ROC) analysis based on observed patient data. Among the 120 enrolled patients, a proportion developed AKI during the 24-hour postoperative observation period (final numbers provided in the Results section). Patients who developed AKI demonstrated distinct perioperative alterations in specific exosomal miRNAs compared with those who did not develop AKI. Several miRNAs showed measurable discriminatory ability for early AKI detection across different sampling time points, with areas under the ROC curve (AUCs) ranging within clinically relevant thresholds (AUC values reported in the Results and Tables following recalculation using observed data with 95% confidence intervals). These findings suggest that perioperative plasma exosomal miRNAs may serve as promising early indicators of acute kidney injury in septic patients undergoing major surgery. Their potential role in identifying subclinical AKI warrants further investigation in studies specifically powered for this endpoint.